Quantitative real-time RT-PCR of ITGA7, SVEP1, TNS1, LPHN3, SEMA3G, KLB and MMP13 mRNA expression in breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5879-5882

  Kotepui, Manas ^a   Thawornkuno, Charin ^a   Chavalitshewinkoon Petmitr, Porntip ^b   Punyarit, Phaibul ^c   Petmitr, Songsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Army Institute of Pathology   (Thailand)

Author keywords

Breast cancer; LPHN3; Lymph node metastasis; MMP13

Indexed keywords

EID: 84874071429     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5879     Document Type: Article

References (30)

1. Berger J, Mueller-Holzner E, Fiegl H, Marth C, Daxenbichler G (2006). Evaluation of three mRNA markers for the detection of lymph node metastases. Anticancer Res, 26, 3855-60.
2. Bin Sun H, Ruan Y, Xu ZC, Yokota H (2002). Involvement of the calcium-independent receptor for alpha-latrotoxin in brain ischemia. Brain Res Mol Brain Res, 104, 246-9.
3. Cabioglu N, Yazici MS, Arun B, et al (2005). CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res, 11, 5686-93.
4. Denninghoff V, Allende D, Paesani F, et al (2008). Sentinel lymph node molecular pathology in breast carcinoma. Diagn Mol Pathol, 17, 214-9.
5. Elnemr A, Yonemura Y, Bandou E, et al (2003). Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer, 6, 30-8.
6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
7. Fisher B, Bauer M, Wickerham DL, et al (1983). Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer, 52, 1551-7.
8. Fisher ER, Costantino J, Fisher B, et al (1995). Pathologic findings from the national surgical adjuvant breast project (nsabp) protocol b-17. Intraductal carcinoma (ductal carcinoma in situ). The national surgical adjuvant breast and bowel project collaborating investigators. Cancer, 75, 1310-9.
9. Hall EH, Daugherty AE, Choi CK, Horwitz AF, Brautigan DL (2009). Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem, 284, 34713-22.
10. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999). Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol, 17, 2334-40.
11. Karayan-Tapon L, Wager M, Guilhot J, et al (2008). Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?. Br J Cancer, 99, 1153-60.
12. Kenemans P, Verstraeten RA, Verheijen RH (2008). Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas, 61, 141-50.
13. Lederle W, Hartenstein B, Meides A, et al (2010). MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis, 31, 1175-84.
14. Luukkaa M, Vihinen P, Kronqvist P, et al (2006). Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck, 28, 225-34.
15. Martinez AF, Muenke M, Arcos-Burgos M (2011). From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet, 156B, 1-10.
16. Nakagawa T, Martinez SR, Goto Y, et al (2007). Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res, 13, 4105-10.
17. Nan Hu LQ, Ying Hu, Jian-Zhong Shou, et al (2006). Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL and EVPL in esophageal squamous cell carcinoma. BMC Cancer, 6, 33.
18. Nielsen BS, Rank F, López JM, et al (2001). Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res, 61, 7091-100.
19. Paper W, Kroeber M, Heersink S, et al (2008). Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression. Exp Eye Res, 87, 257-67.
20. Pendás AM, Uría JA, Jiménez MG, et al (2000). An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta, 291, 137-55.
21. Shur I, Zemer-Tov E, Socher R, Benayahu D (2007). SVEP1 expression is regulated in estrogen-dependent manner. J Cell Physiol, 210, 732-9.
22. Thongwatchara P, Promwikorn W, Srisomsap C, et al (2011). Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol Rep, 26, 185-91.
23. Wallwiener CW, Wallwiener M, Kurth RR, et al (2011). Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels. Breast Cancer Res Treat, 130, 833-44.
24. Wallis D, Hill DS, Mendez IA, et al (2012). Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. Brain Res, 1463, 85-92.
25. Xing Y, Nakamura Y, Rainey WE (2009). G protein-coupled receptor expression in the adult and fetal adrenal glands. Mol Cell Endocrinol, 300, 43-50.
26. Yang C, Liu F, Li S, et al (2012). Lymph Node Ratio: A New Feature for Defining Risk Category of Node-Positive Breast Cancer Patients. Int J Surg Pathol, ?, ?-?.
27. Yang C, Jin C, Li X, et al (2012). Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. PLoS One, 7, 33870.
28. Yenidunya S, Bayrak R, Haltas H (2011). Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma. Diagn Pathol, 6, 18.
29. Yu D, Hung MC (2000). Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene, 19, 6115-21.
30. Zhu ZH, Yu YP, Zheng ZL, et al (2010). Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death. Am J Pathol, 177, 1176-86.